Nanjing Superyears Gene Technology Co., Ltd.
PrivateLast Round
Series A
Sep 24, 2023
Total Funding Raised
$8.24M
Company Overview
Nanjing Superyears Gene Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Series A round in September 2023.
Nanjing Superyears Gene Technology Co., Ltd. is a biotechnology company that develops and manufactures high-end scientific instruments, including genetic analyzers and real-time PCR systems.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Superyears Gene Technology Co., Ltd. Comparables
Compare Nanjing Superyears Gene Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jiangsu Superbio Biomedical Co., Ltd. | 89% | |
| Ningbo HEALTH Gene Technologies Co., Ltd. | 86% | |
| Denogen (Beijing) Bio-Sci&Tech Co., Ltd. | 86% |
For institutional investors. Book with your work email.
Nanjing Superyears Gene Technology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanjing Superyears Gene Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anhui Guokong Capital Co., Ltd. | Series A |
Nanjing Superyears Gene Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanjing Superyears Gene Technology Co., Ltd.'s valuation, stock price, and market status.
Is Nanjing Superyears Gene Technology Co., Ltd. a public or private company?
Nanjing Superyears Gene Technology Co., Ltd. is a private company.
What is the current stock price of Nanjing Superyears Gene Technology Co., Ltd.?
Nanjing Superyears Gene Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nanjing Superyears Gene Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanjing Superyears Gene Technology Co., Ltd. worth (valuation)?
Valuation information for Nanjing Superyears Gene Technology Co., Ltd. is not publicly available.
Can I buy Nanjing Superyears Gene Technology Co., Ltd. stock?
Nanjing Superyears Gene Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanjing Superyears Gene Technology Co., Ltd.'s last funding round?
Nanjing Superyears Gene Technology Co., Ltd.'s most recent funding round was Series A on September 24, 2023.
Who are the main investors in Nanjing Superyears Gene Technology Co., Ltd.?
Key investors in Nanjing Superyears Gene Technology Co., Ltd. include Anhui Guokong Capital Co., Ltd..
Will Nanjing Superyears Gene Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Nanjing Superyears Gene Technology Co., Ltd..
How can I track Nanjing Superyears Gene Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nanjing Superyears Gene Technology Co., Ltd.'s shares on secondary markets.